Legionella Testing Market: By Antibiotics, By Test Type, By End-User & By Geography - Forecast 2016-2021

  • ID: 3974220
  • Report
  • 158 pages
  • IndustryARC
1 of 3
Legionella is a type of bacteria that can cause a serious form of pneumonia called Legionnaires disease or flu like illness. Legionella testing detects the presence of the bacteria to help diagnose the cause of a person's pneumonia. Globally, increasing incidences of legionella based diseases, and advancement in immunodiagnostic technologies and automation are the prime growth drivers of global legionella testing market. In addition, emerging economies such as China, India and others will create new opportunities for global legionella testing market. However, high cost of device and lack of awareness about legionella based diseases and outbreak are the key restraints for global legionella testing market.

This report identifies the global legionella testing market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global legionella testing market.

Geographically North America dominated global legionella testing market, due to growing number of patients suffering from Legionella infections and presence of large number of market players in this region. Europe is projected to have fastest growth, owing to extensive promotion and funding for healthcare facilities by the European government such as Germany and the U.K. Among all the end-users, hospital segment has the highest market share in global legionella testing market. Azithromycin drug is forecast to grow at the fastest rate throughout the forecast period. Azithromycin drug is mainly used for treating this infection in children and adults. Rapidly rising incidences of legionella based diseases in children and adults will propel the growth of Azithromycin drug.

This report segments global legionella testing market on the basis of product, technology, application, end-user, and regional market as follows:

Legionella Testing Market, By Antibiotics: Rifampin, Azithromycin, Ketolides, Quinolones and Macrolides
Legionella Testing Market, By Test Type: Sputum or Lung Tissue Test, Urine Antigen Test, Chest X-ray, and Blood Test
The report has focused study on legionella testing market by basis of end-user such as: Hospitals, Commercial or Private Labs, Physician Offices, and Public Health Labs
This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the legionella testing market. Some of the major companies’ profiles in detail are as follows:

Roche Diagnostics
Beckman Coulter
Bio Rad
Novartis Diagnostics
Life Technology
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Legionella Testing – Market Overview

2. Executive Summary

3. Legionella Testing Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis

4. Legionella Testing – Market Forces
4.1. Drivers
4.1.1. Increasing incidences of legionella based diseases
4.1.2. Advancement in immunodiagnostic technologies and automation
4.2. Restraints
4.2.1. High cost of device
4.2.2. Lack of awareness
4.3. Opportunities
4.3.1. Emerging economies
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Legionella Testing Market, By Antibiotics
5.1. Rifampin
5.2. Azithromycin
5.3. Ketolides
5.4. Quinolones
5.5. Macrolides

6. Legionella Testing Market, By Test Type
6.1. Sputum or Lung Tissue Test
6.2. Urine Antigen Test
6.3. Chest X-ray
6.4. Blood Test

7. Legionella Testing Market, By End-User
7.1. Hospitals
7.2. Commercial or Private Labs
7.3. Physician Offices
7.4. Public Health Labs

8. Global Legionella Testing Market, By Geography (2014-2021)
8.1. Europe
8.1.1. Germany
8.1.2. France
8.1.3. Italy
8.1.4. Spain
8.1.5. Russia
8.1.6. U.K.
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.3.1. U.S.
8.3.2. Canada
8.3.3. Mexico
8.4. Rest of the World (RoW)
8.4.1. Brazil
8.4.2. Rest of RoW

9. Legionella Testing – Market Entropy
9.1. Expansion
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract

10. Company Profiles (Top 10 Companies)
10.1. Roche Diagnostics
10.1.1. Introduction
10.1.2. Financials
10.1.3. Key Insights
10.1.4. Key Strategy
10.1.5. Product Portfolio
10.1.6. SWOT Analysis
10.2. Beckman Coulter
10.2.1. Introduction
10.2.2. Financials
10.2.3. Key Insights
10.2.4. Key Strategy
10.2.5. Product Portfolio
10.2.6. SWOT Analysis
10.3. Bio Rad
10.3.1. Introduction
10.3.2. Financials
10.3.3. Key Insights
10.3.4. Key Strategy
10.3.5. Product Portfolio
10.3.6. SWOT Analysis
10.4. Novartis Diagnostics
10.4.1. Introduction
10.4.2. Financials
10.4.3. Key Insights
10.4.4. Key Strategy
10.4.5. Product Portfolio
10.4.6. SWOT Analysis
10.5. Life Technology
10.5.1. Introduction
10.5.2. Financials
10.5.3. Key Insights
10.5.4. Key Strategy
10.5.5. Product Portfolio
10.5.6. SWOT Analysis
10.6. Becton Dickinson
10.6.1. Introduction
10.6.2. Financials
10.6.3. Key Insights
10.6.4. Key Strategy
10.6.5. Product Portfolio
10.6.6. SWOT Analysis
10.7. Abott laboratories
10.7.1. Introduction
10.7.2. Financials
10.7.3. Key Insights
10.7.4. Key Strategy
10.7.5. Product Portfolio
10.7.6. SWOT Analysis
10.8. Eiken Chemical
10.8.1. Introduction
10.8.2. Financials
10.8.3. Key Insights
10.8.4. Key Strategy
10.8.5. Product Portfolio
10.8.6. SWOT Analysis
10.9. ID Biomedical
10.9.1. Introduction
10.9.2. Financials
10.9.3. Key Insights
10.9.4. Key Strategy
10.9.5. Product Portfolio
10.9.6. SWOT Analysis
10.10. Thermo Fischer
10.10.1. Introduction
10.10.2. Financials
10.10.3. Key Insights
10.10.4. Key Strategy
10.10.5. Product Portfolio
10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown